Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BGY | 5.49 | 0.03 | +0.55% |
| BlackRock Enhanced International Dividend Trust | |||
| SLYG | 108.16 | 0.29 | +0.27% |
| State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) | |||
| POWA | 91.61 | 0.14 | +0.15% |
| Invesco Bloomberg Pricing Power ETF (POWA) | |||
| DIVE | 28.09 | 0.01 | +0.02% |
| Dana Concentrated Dividend ETF (DIVE) | |||
| KNOW | 12.83 | N/A | N/A |
| Fundamentals First ETF (KNOW) | |||
A.I.dvisor indicates that over the last year, NOVT has been loosely correlated with ST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NOVT jumps, then ST could also see price increases.
| Ticker / NAME | Correlation To NOVT | 1D Price Change % | ||
|---|---|---|---|---|
| NOVT | 100% | +3.21% | ||
| ST - NOVT | 52% Loosely correlated | +0.67% | ||
| VPG - NOVT | 51% Loosely correlated | +4.29% | ||
| BKSY - NOVT | 40% Loosely correlated | +2.85% | ||
| CGNX - NOVT | 38% Loosely correlated | +2.25% | ||
| KEYS - NOVT | 35% Loosely correlated | +2.15% | ||
More | ||||
a developer of manufactures and sells precision photonic and motion control components
Industry ElectronicEquipmentInstruments
NOVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 43 cases where NOVT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NOVT's RSI Oscillator exited the oversold zone, 17 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 64 cases where NOVT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
Following a +6.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOVT advanced for three days, in 196 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NOVT as a result. In 72 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for NOVT turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 35 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
NOVT moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
The Aroon Indicator for NOVT entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. NOVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.274) is normal, around the industry mean (1.792). P/E Ratio (88.013) is within average values for comparable stocks, (7.746). NOVT's Projected Growth (PEG Ratio) (23.270) is slightly higher than the industry average of (5.470). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.043) is also within normal values, averaging (32.028).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.